 | • レポートコード：MRC2-11QY11368 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は慢性リンパ性白血病（CLL）治療薬のグローバル市場について調査・分析したレポートです。種類別（注射式、経口式）市場規模、用途別（病院、クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別慢性リンパ性白血病（CLL）治療薬の競争状況、市場シェア ・世界の慢性リンパ性白血病（CLL）治療薬市場：種類別市場規模 2015年-2020年（注射式、経口式） ・世界の慢性リンパ性白血病（CLL）治療薬市場：種類別市場規模予測 2021年-2026年（注射式、経口式） ・世界の慢性リンパ性白血病（CLL）治療薬市場：用途別市場規模 2015年-2020年（病院、クリニック） ・世界の慢性リンパ性白血病（CLL）治療薬市場：用途別市場規模予測 2021年-2026年（病院、クリニック） ・北米の慢性リンパ性白血病（CLL）治療薬市場分析：米国、カナダ ・ヨーロッパの慢性リンパ性白血病（CLL）治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの慢性リンパ性白血病（CLL）治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の慢性リンパ性白血病（CLL）治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの慢性リンパ性白血病（CLL）治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Pfizer、Amgen、Abbott、Roche AG、Novartis、Johnson and Johnson、Sanofi Genzyme Corporation、Akebia Therapeutics、Celgene Corporation、Genmab A/S ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Chronic Lymphocytic Leukemia Therapeutics Market
The global Chronic Lymphocytic Leukemia Therapeutics market size is projected to reach US$ 9390.9 million by 2026, from US$ 8411.2 million in 2020, at a CAGR of 10.8%% during 2021-2026.
Global Chronic Lymphocytic Leukemia Therapeutics Scope and Market Size
Chronic Lymphocytic Leukemia Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Chronic Lymphocytic Leukemia Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Pfizer
Amgen
Abbott
Roche AG
Novartis
Johnson and Johnson
Sanofi Genzyme Corporation
Akebia Therapeutics
Celgene Corporation
Genmab A/S
Market segment by Type, the product can be split into
Injection Type
Oral Type
Market segment by Application, split into
Hospitals
Clinics
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Chronic Lymphocytic Leukemia Therapeutics Revenue
1.4 Market by Type
1.4.1 Global Chronic Lymphocytic Leukemia Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Injection Type
1.4.3 Oral Type
1.5 Market by Application
1.5.1 Global Chronic Lymphocytic Leukemia Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Chronic Lymphocytic Leukemia Therapeutics Market Perspective (2015-2026)
2.2 Global Chronic Lymphocytic Leukemia Therapeutics Growth Trends by Regions
2.2.1 Chronic Lymphocytic Leukemia Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Chronic Lymphocytic Leukemia Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Chronic Lymphocytic Leukemia Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Chronic Lymphocytic Leukemia Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Chronic Lymphocytic Leukemia Therapeutics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Chronic Lymphocytic Leukemia Therapeutics Players by Market Size
3.1.1 Global Top Chronic Lymphocytic Leukemia Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Chronic Lymphocytic Leukemia Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Chronic Lymphocytic Leukemia Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Chronic Lymphocytic Leukemia Therapeutics Market Concentration Ratio
3.2.1 Global Chronic Lymphocytic Leukemia Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Chronic Lymphocytic Leukemia Therapeutics Revenue in 2019
3.3 Chronic Lymphocytic Leukemia Therapeutics Key Players Head office and Area Served
3.4 Key Players Chronic Lymphocytic Leukemia Therapeutics Product Solution and Service
3.5 Date of Enter into Chronic Lymphocytic Leukemia Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Chronic Lymphocytic Leukemia Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Chronic Lymphocytic Leukemia Therapeutics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Chronic Lymphocytic Leukemia Therapeutics Market Size by Application (2015-2020)
5.2 Global Chronic Lymphocytic Leukemia Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Chronic Lymphocytic Leukemia Therapeutics Market Size (2015-2020)
6.2 Chronic Lymphocytic Leukemia Therapeutics Key Players in North America (2019-2020)
6.3 North America Chronic Lymphocytic Leukemia Therapeutics Market Size by Type (2015-2020)
6.4 North America Chronic Lymphocytic Leukemia Therapeutics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Chronic Lymphocytic Leukemia Therapeutics Market Size (2015-2020)
7.2 Chronic Lymphocytic Leukemia Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Chronic Lymphocytic Leukemia Therapeutics Market Size by Type (2015-2020)
7.4 Europe Chronic Lymphocytic Leukemia Therapeutics Market Size by Application (2015-2020)
8 China
8.1 China Chronic Lymphocytic Leukemia Therapeutics Market Size (2015-2020)
8.2 Chronic Lymphocytic Leukemia Therapeutics Key Players in China (2019-2020)
8.3 China Chronic Lymphocytic Leukemia Therapeutics Market Size by Type (2015-2020)
8.4 China Chronic Lymphocytic Leukemia Therapeutics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Chronic Lymphocytic Leukemia Therapeutics Market Size (2015-2020)
9.2 Chronic Lymphocytic Leukemia Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Chronic Lymphocytic Leukemia Therapeutics Market Size by Type (2015-2020)
9.4 Japan Chronic Lymphocytic Leukemia Therapeutics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Chronic Lymphocytic Leukemia Therapeutics Market Size (2015-2020)
10.2 Chronic Lymphocytic Leukemia Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Chronic Lymphocytic Leukemia Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Chronic Lymphocytic Leukemia Therapeutics Market Size by Application (2015-2020)
11 India
11.1 India Chronic Lymphocytic Leukemia Therapeutics Market Size (2015-2020)
11.2 Chronic Lymphocytic Leukemia Therapeutics Key Players in India (2019-2020)
11.3 India Chronic Lymphocytic Leukemia Therapeutics Market Size by Type (2015-2020)
11.4 India Chronic Lymphocytic Leukemia Therapeutics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Chronic Lymphocytic Leukemia Therapeutics Market Size (2015-2020)
12.2 Chronic Lymphocytic Leukemia Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Chronic Lymphocytic Leukemia Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Chronic Lymphocytic Leukemia Therapeutics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Pfizer
13.1.1 Pfizer Company Details
13.1.2 Pfizer Business Overview
13.1.3 Pfizer Chronic Lymphocytic Leukemia Therapeutics Introduction
13.1.4 Pfizer Revenue in Chronic Lymphocytic Leukemia Therapeutics Business (2015-2020))
13.1.5 Pfizer Recent Development
13.2 Amgen
13.2.1 Amgen Company Details
13.2.2 Amgen Business Overview
13.2.3 Amgen Chronic Lymphocytic Leukemia Therapeutics Introduction
13.2.4 Amgen Revenue in Chronic Lymphocytic Leukemia Therapeutics Business (2015-2020)
13.2.5 Amgen Recent Development
13.3 Abbott
13.3.1 Abbott Company Details
13.3.2 Abbott Business Overview
13.3.3 Abbott Chronic Lymphocytic Leukemia Therapeutics Introduction
13.3.4 Abbott Revenue in Chronic Lymphocytic Leukemia Therapeutics Business (2015-2020)
13.3.5 Abbott Recent Development
13.4 Roche AG
13.4.1 Roche AG Company Details
13.4.2 Roche AG Business Overview
13.4.3 Roche AG Chronic Lymphocytic Leukemia Therapeutics Introduction
13.4.4 Roche AG Revenue in Chronic Lymphocytic Leukemia Therapeutics Business (2015-2020)
13.4.5 Roche AG Recent Development
13.5 Novartis
13.5.1 Novartis Company Details
13.5.2 Novartis Business Overview
13.5.3 Novartis Chronic Lymphocytic Leukemia Therapeutics Introduction
13.5.4 Novartis Revenue in Chronic Lymphocytic Leukemia Therapeutics Business (2015-2020)
13.5.5 Novartis Recent Development
13.6 Johnson and Johnson
13.6.1 Johnson and Johnson Company Details
13.6.2 Johnson and Johnson Business Overview
13.6.3 Johnson and Johnson Chronic Lymphocytic Leukemia Therapeutics Introduction
13.6.4 Johnson and Johnson Revenue in Chronic Lymphocytic Leukemia Therapeutics Business (2015-2020)
13.6.5 Johnson and Johnson Recent Development
13.7 Sanofi Genzyme Corporation
13.7.1 Sanofi Genzyme Corporation Company Details
13.7.2 Sanofi Genzyme Corporation Business Overview
13.7.3 Sanofi Genzyme Corporation Chronic Lymphocytic Leukemia Therapeutics Introduction
13.7.4 Sanofi Genzyme Corporation Revenue in Chronic Lymphocytic Leukemia Therapeutics Business (2015-2020)
13.7.5 Sanofi Genzyme Corporation Recent Development
13.8 Akebia Therapeutics
13.8.1 Akebia Therapeutics Company Details
13.8.2 Akebia Therapeutics Business Overview
13.8.3 Akebia Therapeutics Chronic Lymphocytic Leukemia Therapeutics Introduction
13.8.4 Akebia Therapeutics Revenue in Chronic Lymphocytic Leukemia Therapeutics Business (2015-2020)
13.8.5 Akebia Therapeutics Recent Development
13.9 Celgene Corporation
13.9.1 Celgene Corporation Company Details
13.9.2 Celgene Corporation Business Overview
13.9.3 Celgene Corporation Chronic Lymphocytic Leukemia Therapeutics Introduction
13.9.4 Celgene Corporation Revenue in Chronic Lymphocytic Leukemia Therapeutics Business (2015-2020)
13.9.5 Celgene Corporation Recent Development
13.10 Genmab A/S
13.10.1 Genmab A/S Company Details
13.10.2 Genmab A/S Business Overview
13.10.3 Genmab A/S Chronic Lymphocytic Leukemia Therapeutics Introduction
13.10.4 Genmab A/S Revenue in Chronic Lymphocytic Leukemia Therapeutics Business (2015-2020)
13.10.5 Genmab A/S Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Chronic Lymphocytic Leukemia Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Chronic Lymphocytic Leukemia Therapeutics Revenue
Table 3. Ranking of Global Top Chronic Lymphocytic Leukemia Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Chronic Lymphocytic Leukemia Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Injection Type
Table 6. Key Players of Oral Type
Table 7. Global Chronic Lymphocytic Leukemia Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Chronic Lymphocytic Leukemia Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Chronic Lymphocytic Leukemia Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Chronic Lymphocytic Leukemia Therapeutics Market Share by Regions (2015-2020)
Table 11. Global Chronic Lymphocytic Leukemia Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Chronic Lymphocytic Leukemia Therapeutics Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Chronic Lymphocytic Leukemia Therapeutics Market Growth Strategy
Table 17. Main Points Interviewed from Key Chronic Lymphocytic Leukemia Therapeutics Players
Table 18. Global Chronic Lymphocytic Leukemia Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 19. Global Chronic Lymphocytic Leukemia Therapeutics Market Share by Players (2015-2020)
Table 20. Global Top Chronic Lymphocytic Leukemia Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Lymphocytic Leukemia Therapeutics as of 2019)
Table 21. Global Chronic Lymphocytic Leukemia Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Chronic Lymphocytic Leukemia Therapeutics Product Solution and Service
Table 24. Date of Enter into Chronic Lymphocytic Leukemia Therapeutics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Chronic Lymphocytic Leukemia Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 27. Global Chronic Lymphocytic Leukemia Therapeutics Market Size Share by Type (2015-2020)
Table 28. Global Chronic Lymphocytic Leukemia Therapeutics Revenue Market Share by Type (2021-2026)
Table 29. Global Chronic Lymphocytic Leukemia Therapeutics Market Size Share by Application (2015-2020)
Table 30. Global Chronic Lymphocytic Leukemia Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 31. Global Chronic Lymphocytic Leukemia Therapeutics Market Size Share by Application (2021-2026)
Table 32. North America Key Players Chronic Lymphocytic Leukemia Therapeutics Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Chronic Lymphocytic Leukemia Therapeutics Market Share (2019-2020)
Table 34. North America Chronic Lymphocytic Leukemia Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 35. North America Chronic Lymphocytic Leukemia Therapeutics Market Share by Type (2015-2020)
Table 36. North America Chronic Lymphocytic Leukemia Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 37. North America Chronic Lymphocytic Leukemia Therapeutics Market Share by Application (2015-2020)
Table 38. Europe Key Players Chronic Lymphocytic Leukemia Therapeutics Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Chronic Lymphocytic Leukemia Therapeutics Market Share (2019-2020)
Table 40. Europe Chronic Lymphocytic Leukemia Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Chronic Lymphocytic Leukemia Therapeutics Market Share by Type (2015-2020)
Table 42. Europe Chronic Lymphocytic Leukemia Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Chronic Lymphocytic Leukemia Therapeutics Market Share by Application (2015-2020)
Table 44. China Key Players Chronic Lymphocytic Leukemia Therapeutics Revenue (2019-2020) (Million US$)
Table 45. China Key Players Chronic Lymphocytic Leukemia Therapeutics Market Share (2019-2020)
Table 46. China Chronic Lymphocytic Leukemia Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 47. China Chronic Lymphocytic Leukemia Therapeutics Market Share by Type (2015-2020)
Table 48. China Chronic Lymphocytic Leukemia Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 49. China Chronic Lymphocytic Leukemia Therapeutics Market Share by Application (2015-2020)
Table 50. Japan Key Players Chronic Lymphocytic Leukemia Therapeutics Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Chronic Lymphocytic Leukemia Therapeutics Market Share (2019-2020)
Table 52. Japan Chronic Lymphocytic Leukemia Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Chronic Lymphocytic Leukemia Therapeutics Market Share by Type (2015-2020)
Table 54. Japan Chronic Lymphocytic Leukemia Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Chronic Lymphocytic Leukemia Therapeutics Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Chronic Lymphocytic Leukemia Therapeutics Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Chronic Lymphocytic Leukemia Therapeutics Market Share (2019-2020)
Table 58. Southeast Asia Chronic Lymphocytic Leukemia Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Chronic Lymphocytic Leukemia Therapeutics Market Share by Type (2015-2020)
Table 60. Southeast Asia Chronic Lymphocytic Leukemia Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Chronic Lymphocytic Leukemia Therapeutics Market Share by Application (2015-2020)
Table 62. India Key Players Chronic Lymphocytic Leukemia Therapeutics Revenue (2019-2020) (Million US$)
Table 63. India Key Players Chronic Lymphocytic Leukemia Therapeutics Market Share (2019-2020)
Table 64. India Chronic Lymphocytic Leukemia Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 65. India Chronic Lymphocytic Leukemia Therapeutics Market Share by Type (2015-2020)
Table 66. India Chronic Lymphocytic Leukemia Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 67. India Chronic Lymphocytic Leukemia Therapeutics Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Chronic Lymphocytic Leukemia Therapeutics Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Chronic Lymphocytic Leukemia Therapeutics Market Share (2019-2020)
Table 70. Central & South America Chronic Lymphocytic Leukemia Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Chronic Lymphocytic Leukemia Therapeutics Market Share by Type (2015-2020)
Table 72. Central & South America Chronic Lymphocytic Leukemia Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Chronic Lymphocytic Leukemia Therapeutics Market Share by Application (2015-2020)
Table 74. Pfizer Company Details
Table 75. Pfizer Business Overview
Table 76. Pfizer Product
Table 77. Pfizer Revenue in Chronic Lymphocytic Leukemia Therapeutics Business (2015-2020) (Million US$)
Table 78. Pfizer Recent Development
Table 79. Amgen Company Details
Table 80. Amgen Business Overview
Table 81. Amgen Product
Table 82. Amgen Revenue in Chronic Lymphocytic Leukemia Therapeutics Business (2015-2020) (Million US$)
Table 83. Amgen Recent Development
Table 84. Abbott Company Details
Table 85. Abbott Business Overview
Table 86. Abbott Product
Table 87. Abbott Revenue in Chronic Lymphocytic Leukemia Therapeutics Business (2015-2020) (Million US$)
Table 88. Abbott Recent Development
Table 89. Roche AG Company Details
Table 90. Roche AG Business Overview
Table 91. Roche AG Product
Table 92. Roche AG Revenue in Chronic Lymphocytic Leukemia Therapeutics Business (2015-2020) (Million US$)
Table 93. Roche AG Recent Development
Table 94. Novartis Company Details
Table 95. Novartis Business Overview
Table 96. Novartis Product
Table 97. Novartis Revenue in Chronic Lymphocytic Leukemia Therapeutics Business (2015-2020) (Million US$)
Table 98. Novartis Recent Development
Table 99. Johnson and Johnson Company Details
Table 100. Johnson and Johnson Business Overview
Table 101. Johnson and Johnson Product
Table 102. Johnson and Johnson Revenue in Chronic Lymphocytic Leukemia Therapeutics Business (2015-2020) (Million US$)
Table 103. Johnson and Johnson Recent Development
Table 104. Sanofi Genzyme Corporation Company Details
Table 105. Sanofi Genzyme Corporation Business Overview
Table 106. Sanofi Genzyme Corporation Product
Table 107. Sanofi Genzyme Corporation Revenue in Chronic Lymphocytic Leukemia Therapeutics Business (2015-2020) (Million US$)
Table 108. Sanofi Genzyme Corporation Recent Development
Table 109. Akebia Therapeutics Business Overview
Table 110. Akebia Therapeutics Product
Table 111. Akebia Therapeutics Company Details
Table 112. Akebia Therapeutics Revenue in Chronic Lymphocytic Leukemia Therapeutics Business (2015-2020) (Million US$)
Table 113. Akebia Therapeutics Recent Development
Table 114. Celgene Corporation Company Details
Table 115. Celgene Corporation Business Overview
Table 116. Celgene Corporation Product
Table 117. Celgene Corporation Revenue in Chronic Lymphocytic Leukemia Therapeutics Business (2015-2020) (Million US$)
Table 118. Celgene Corporation Recent Development
Table 119. Genmab A/S Company Details
Table 120. Genmab A/S Business Overview
Table 121. Genmab A/S Product
Table 122. Genmab A/S Revenue in Chronic Lymphocytic Leukemia Therapeutics Business (2015-2020) (Million US$)
Table 123. Genmab A/S Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Chronic Lymphocytic Leukemia Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Injection Type Features
Figure 3. Oral Type Features
Figure 4. Global Chronic Lymphocytic Leukemia Therapeutics Market Share by Application: 2020 VS 2026
Figure 5. Hospitals Case Studies
Figure 6. Clinics Case Studies
Figure 7. Chronic Lymphocytic Leukemia Therapeutics Report Years Considered
Figure 8. Global Chronic Lymphocytic Leukemia Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 9. Global Chronic Lymphocytic Leukemia Therapeutics Market Share by Regions: 2020 VS 2026
Figure 10. Global Chronic Lymphocytic Leukemia Therapeutics Market Share by Regions (2021-2026)
Figure 11. Porter's Five Forces Analysis
Figure 12. Global Chronic Lymphocytic Leukemia Therapeutics Market Share by Players in 2019
Figure 13. Global Top Chronic Lymphocytic Leukemia Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Lymphocytic Leukemia Therapeutics as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Chronic Lymphocytic Leukemia Therapeutics Revenue in 2019
Figure 15. North America Chronic Lymphocytic Leukemia Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 16. Europe Chronic Lymphocytic Leukemia Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. China Chronic Lymphocytic Leukemia Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Japan Chronic Lymphocytic Leukemia Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Southeast Asia Chronic Lymphocytic Leukemia Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. India Chronic Lymphocytic Leukemia Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Central & South America Chronic Lymphocytic Leukemia Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Bottom-up and Top-down Approaches for This Report
Figure 23. Data Triangulation
Figure 24. Key Executives Interviewed
慢性リンパ性白血病（CLL）治療の世界市場（～2026年） Accumulation of functionally incompetent monocytes is referred as Chronic Lymphocytic Leukemia (CLL). Chronic Lymphocytic Leukemia is a type of monoclonal disorder and is commonly found in adults in western countries. Based on the severity, patients diagnosed with chronic lymphocytic leukemia die wi…- B細胞慢性リンパ球性白血病治療の世界市場（～2026年） Market Analysis and Insights: Global B-Cell Chronic Lymphocytic Leukemia Treatment Market The global B-Cell Chronic Lymphocytic Leukemia Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global B-Cell Chronic Lymphocy…
- 慢性骨髄性白血病治療の世界市場（～2026年） Chronic myeloid leukemia (CML) is also known as chronic myelogenous leukemia. It's a type of cancer that starts in certain blood-forming cells of the bone marrow. Market Analysis and Insights: Global Chronic Myelogenous Leukemia Treatment Market The global Chronic Myelogenous Leukemia Treatment mark…
- 有毛細胞白血病治療薬の世界市場（～2026年） Market Analysis and Insights: Global Hairy Cell Leukemia Therapeutics Market The global Hairy Cell Leukemia Therapeutics market size is projected to reach US$ 90 million by 2026, from US$ 86 million in 2020, at a CAGR of 4.8%% during 2021-2026. Global Hairy Cell Leukemia Therapeutics Scope and Marke…
- 急性骨髄性白血病治療薬の世界市場（～2026年） Acute myeloid leukemia is the second frequent type (after acute lymphocytic leukemia) of leukemia diagnosed in infants. About 15% of children from birth to 19 years of age diagnosed with leukemia have acute myeloid leukemia. The risk of acute myeloid leukemia is closely associated with age. About 90…